Literature DB >> 12717013

Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor.

Eva Y Chi1, Sampathkumar Krishnan, Brent S Kendrick, Byeong S Chang, John F Carpenter, Theodore W Randolph.   

Abstract

We studied the non-native aggregation of recombinant human granulocyte stimulating factor (rhGCSF) in solution conditions where native rhGCSF is both conformationally stable compared to its unfolded state and at concentrations well below its solubility limit. Aggregation of rhGCSF first involves the perturbation of its native structure to form a structurally expanded transition state, followed by assembly process to form an irreversible aggregate. The energy barriers of the two steps are reflected in the experimentally measured values of free energy of unfolding (DeltaG(unf)) and osmotic second virial coefficient (B(22)), respectively. Under solution conditions where rhGCSF conformational stability dominates (i.e., large DeltaG(unf) and negative B(22)), the first step is rate-limiting, and increasing DeltaG(unf) (e.g., by the addition of sucrose) decreases aggregation. In solutions where colloidal stability is high (i.e., large and positive B(22) values) the second step is rate-limiting, and solution conditions (e.g., low pH and low ionic strength) that increase repulsive interactions between protein molecules are effective at reducing aggregation. rhGCSF aggregation is thus controlled by both conformational stability and colloidal stability, and depending on the solution conditions, either could be rate-limiting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717013      PMCID: PMC2323861          DOI: 10.1110/ps.0235703

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  30 in total

1.  Interactions and aggregation of apoferritin molecules in solution: effects of added electrolytes.

Authors:  D N Petsev; B R Thomas; S Yau; P G Vekilov
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

2.  Phase behavior of small attractive colloidal particles.

Authors: 
Journal:  Phys Rev Lett       Date:  1996-01-01       Impact factor: 9.161

3.  Comparative fourier transform infrared and circular dichroism spectroscopic analysis of alpha1-proteinase inhibitor and ovalbumin in aqueous solution.

Authors:  A Dong; J D Meyer; J L Brown; M C Manning; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  2000-11-01       Impact factor: 4.013

4.  Measured and calculated effects of mutations in bacteriophage T4 lysozyme on interactions in solution.

Authors:  R C Chang; D Asthagiri; A M Lenhoff
Journal:  Proteins       Date:  2000-10-01

5.  Protein crystallization by design: chymotrypsinogen without precipitants.

Authors:  P E Pjura; A M Lenhoff; S A Leonard; A G Gittis
Journal:  J Mol Biol       Date:  2000-07-07       Impact factor: 5.469

6.  Protein refolding versus aggregation: computer simulations on an intermediate-resolution protein model.

Authors:  A V Smith; C K Hall
Journal:  J Mol Biol       Date:  2001-09-07       Impact factor: 5.469

7.  Linear extrapolation method of analyzing solvent denaturation curves.

Authors:  C N Pace; K L Shaw
Journal:  Proteins       Date:  2000

8.  Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains.

Authors:  Y S Kim; S P Cape; E Chi; R Raffen; P Wilkins-Stevens; F J Stevens; M C Manning; T W Randolph; A Solomon; J F Carpenter
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

9.  Effect of glycerol on the interactions and solubility of bovine pancreatic trypsin inhibitor.

Authors:  M Farnum; C Zukoski
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

10.  Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: high-pressure and cosolute studies on recombinant human IFN-gamma.

Authors:  J N Webb; S D Webb; J L Cleland; J F Carpenter; T W Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

View more
  62 in total

Review 1.  Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation.

Authors:  Eva Y Chi; Sampathkumar Krishnan; Theodore W Randolph; John F Carpenter
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

2.  Determination of second virial coefficient of proteins using a dual-detector cell for simultaneous measurement of scattered light intensity and concentration in SEC-HPLC.

Authors:  Harminder Bajaj; Vikas K Sharma; Devendra S Kalonia
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

3.  Issues and challenges of subvisible and submicron particulate analysis in protein solutions.

Authors:  Thomas M Scherer; Stephenie Leung; Laura Owyang; Steven J Shire
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

4.  Generation and comparative characterization of glycosylated and aglycosylated human IgG1 antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Hannah Joerissen; Beate Müller-Tiemann; Heiner Apeler; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-03       Impact factor: 2.695

5.  High-throughput analysis of concentration-dependent antibody self-association.

Authors:  Shantanu V Sule; Muppalla Sukumar; William F Weiss; Anna Marie Marcelino-Cruz; Tyler Sample; Peter M Tessier
Journal:  Biophys J       Date:  2011-10-05       Impact factor: 4.033

6.  Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly.

Authors:  Eva Y Chi; Shelli L Frey; Amy Winans; Kin Lok H Lam; Kristian Kjaer; Jaroslaw Majewski; Ka Yee C Lee
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

7.  Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability.

Authors:  Maria A Miller; Tarik A Khan; Kevin J Kaczorowski; Brian K Wilson; Aileen K Dinin; Ameya U Borwankar; Miguel A Rodrigues; Thomas M Truskett; Keith P Johnston; Jennifer A Maynard
Journal:  J Pharm Sci       Date:  2012-07-06       Impact factor: 3.534

Review 8.  With or without sugar? (A)glycosylation of therapeutic antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

Review 9.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

10.  High-pressure refolding of bikunin: efficacy and thermodynamics.

Authors:  Matthew B Seefeldt; Jun Ouyang; Wayne A Froland; John F Carpenter; Theodore W Randolph
Journal:  Protein Sci       Date:  2004-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.